Spring Meeting Announcement

The Behavioral Risk Factor Surveillance System (BRFSS) is the nation’s premier system of health-related telephone surveys that collect state data about U.S. residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services. Established in 1984 with 15 states, BRFSS now collects data in all 50 states as well as the District of Columbia and three U.S. territories. BRFSS completes more than 400,000 adult interviews each year, making it the largest continuously conducted health survey system in the world.

---

 

Save the Date: BRFSS Annual Virtual Meeting
Facing the Challenges of BRFSS Data Modernization
March 21–24, 2022

The Behavioral Risk Factor Surveillance System (BRFSS) is planning its annual spring meeting, which will include state and CDC plenary sessions, training, networking, and gatherings to discuss BRFSS business and issues. This will be a virtual meeting beginning on Monday, March 21, 2022, and lasting through March 24, 2022. Each day will feature different sessions, presentations, and activities for State Coordinators. BRFSS staff hope you will be able to block out some time each day, beginning March 21. Please note the week! Please save some time during these dates to hear about BRFSS events, interact with staff and partners, and share some of your experiences related to collecting, processing, publishing, and using the BRFSS data sets. More information will be provided as it becomes available.

Also:

Please refer to the information below if you are interested in being considered for presenting an oral session/presentation or submitting a virtual poster.

Call for Abstracts for the BRFSS 2022 Virtual Meeting

Attention data researchers and scientists! Abstracts are now being accepted for inclusion in the scientific presentations and posters in the Behavioral Risk Factor Surveillance System (BRFSS) Virtual Meeting, to be held March 21–24, 2022. 

The BRFSS Virtual  Meeting Committee invites you to submit an abstract for a presentation or poster, so your work can be considered for inclusion in the upcoming BRFSS Virtual Meeting:

BRFSS Theme: Facing the Challenges of BRFSS Data Modernization

March 21–24, 2022

The submission deadline is January 31, 2022.
Notifications of accepted presentations will be sent shortly after the closing date, as soon as the review process is complete.

How to Submit an Abstract for Consideration:

*To be considered, all abstracts must meet the abstract criteria listed below.

*Submit your abstracts to BRFSS Submissions (CDC) at brfssabstracts@cdc.gov with the subject line “BRFSS 2022 Abstract Submission”.

Submission Guidelines

 

Abstracts related to BRFSS topics in survey research, epidemiology, evaluation, policy, or public health are welcome for consideration. See the chart below for more information on subject categories.

 

Subject categories:

Call for Abstracts for the BRFSS 2022 Virtual Meeting

Attention data researchers and scientists! Abstracts are now being accepted for inclusion in the scientific presentations and posters in the Behavioral Risk Factor Surveillance System (BRFSS) Virtual Meeting, to be held March 21–24, 2022. 

The BRFSS Virtual Meeting Committee invites you to submit an abstract for a presentation or poster, so your work can be considered for inclusion in the upcoming BRFSS Virtual Meeting:

 

BRFSS Theme: Facing the Challenges of BRFSS Data Modernization

March 21–24, 2022

The submission deadline is January 31, 2022.
Notifications of accepted presentations will be sent shortly after the closing date, as soon as the review process is complete.

How to Submit an Abstract for Consideration:

*To be considered, all abstracts must meet the abstract criteria listed below.

 

*Submit your abstracts to BRFSS Submissions (CDC) at brfssabstracts@cdc.gov with the subject line “BRFSS 2022 Abstract Submission”.

 

Submission Guidelines

Abstracts related to BRFSS topics in survey research, epidemiology, evaluation, policy, or public health are welcome for consideration. See the chart below for more information on subject categories.

 

Subject categories:

 

 

Writing Guidelines for Abstracts

 

The abstract(s) must be:

• Written in English, describing original work.
• Saved in MS Word (.doc or .docx). [If using Information Protection Label Usage Guidelines, please select “General.”]
• Complete; incomplete abstracts will not be accepted.
• Showing the submitter’s information, even if you are submitting an abstract for someone else.
• Left-justified and single-spaced. Leave one line of space before the text following the title, headers, and subheadings. Double-space between paragraphs, but do not indent. Do not use bold, italics, underline, tabs, hard returns, or all capital letters in the abstract text.

 

The abstracts should be divided into the following sections:

 

• Title — Type in a title format with the first letter of a word capitalized.
• Authors — List the primary author first. All authors’ names should begin with the first name; include each author’s degrees without punctuation (e.g., MD, MPH). Underline the presenting author’s name.
• Background — Describe the problem or situation addressed in the abstract.
• Objectives — State the goals of the project.
• Methods — Describe the interventions, activities, programs, etc. used to address the problem.
• Results — Present key findings related to implementation of the methods.
• Conclusions — Summarize lessons learned, plans and directions for future developments, and implications for research and practice.
• Key Words — list 5 key words.
• Learning Objective(s) — State one or two findings that participants should know after attending the presentation.

 

Additional information regarding abstract submissions:

• Length limit: 250 words, not counting title, author names and degrees, headings, key words, objectives, and presenter information.
• No images, charts, or tables are permitted in the abstract.
• Please provide name, position, mailing address, e-mail address, telephone number, and fax number for each presenter, and please indicate the subject category from the chart above that best corresponds to your abstract.
• Final acceptance is contingent upon the self-arranged registration of all presenters.
• Please designate your preference to share your work as a poster, oral presentation, or both.

 

Oral presentations must be no more than 15 minutes in length, with 5 additional minutes allowed for discussion. Presentations addressing the same issue or theme will be grouped together to form a session. Presenters should report recently completed or ongoing work.

 

Poster presentations will be made in a virtual format. The contents of the poster presentation should follow the guidelines listed for abstracts. Results may be summarized in the form of graphs, tables, pictures, etc. Graphic displays should be appropriately labeled and legible.

 

Please submit the above items as separate files; you may attach them to the same email. If you are submitting multiple abstracts, please submit each abstract as a separate file in the same email. Please save the file as presenter’s last name_abstract. If more than one abstract is submitted, add a number after the author’s name for each additional abstract. For example, if the presenter is Jane Smith, the file should be saved as Smith_abstract. If she has multiple abstracts, the second and third ones would be saved as Smith2_abstract and Smith3_abstract, respectively.

 

For questions concerning abstract submission, please send an email to:

BRFSS Submissions (CDC): brfssabstracts@cdc.gov